A single centre intercomparison between commercial treatment planning systems for 90Y radioembolization using virtual and experimental phantoms
The transarterial radioembolization (TARE) with 90Y-loaded microspheres is a well-established targeted radiotherapy procedure for the treatment of primary or secondary liver cancer based on the intra-arterial injection of radioactive compounds. Currently, two types of medical devices have been registered for this purpose, including 90Y-loaded glass (TheraSphereTM, Boston Scientific) and resin (Sir-Spheres, Sirtex) microspheres, that differ in terms of physical properties such as microsphere-specific activity, number of microspheres per injection, and microspheres size, and pre-injection compound preparation [1].
Source: Physica Medica: European Journal of Medical Physics - Category: General Medicine Authors: Giuseppe Della Gala, Miriam Santoro, Garoson Albertine Rasoatsaratanany, Giulia Paolani, Silvia Strolin, Lidia Strigari Tags: Original paper Source Type: research
More News: Cancer | Cancer & Oncology | General Medicine | Liver | Medical Devices | Physics | Urology & Nephrology